(Q42699426)

English

14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid receptor antagonists

scientific article published on November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid receptor antagonists (English)

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

0 references

Jillian H Broadbear

3

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

Stephen M. Husbands

8

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

author name string

Nick P R Nieland

1

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

David Rennison

2

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

Lauren Purington

4

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

James H Woods

5

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

John R Traynor

6

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

John W Lewis

7

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

language of work or name

0 references

publication date

1 November 2009

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

Journal of Medicinal Chemistry

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

52

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

21

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

6926-6930

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effects of changes to the chain linking of the C14-amino group to the aryl ring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788771

27 May 2018

Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788771

27 May 2018

Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788771

27 May 2018

Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788771

27 May 2018

Methoclocinnamox: a mu partial agonist with pharmacotherapeutic potential for heroin abuse.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788771

27 May 2018

Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788771

27 May 2018

Clocinnamox: a novel, systemically-active, irreversible opioid antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788771

27 May 2018

Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2788771

16 August 2018

Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19842669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

14 beta-[(p-nitrocinnamoyl)amino]morphinones, 14 beta-[(p-nitrocinnamoyl)amino]-7,8-dihydromorphinones, and their codeinone analogues: synthesis and receptor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19842669

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1021/JM901074A

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

5 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42699426&oldid=1966301771"